These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23642658)

  • 1. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
    Stahl SM; Porreca F; Taylor CP; Cheung R; Thorpe AJ; Clair A
    Trends Pharmacol Sci; 2013 Jun; 34(6):332-9. PubMed ID: 23642658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha2-delta protein: an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target.
    Thorpe AJ; Offord J
    Curr Opin Investig Drugs; 2010 Jul; 11(7):761-70. PubMed ID: 20571971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
    Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
    Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin: its pharmacology and use in pain management.
    Gajraj NM
    Anesth Analg; 2007 Dec; 105(6):1805-15. PubMed ID: 18042886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect.
    Tuchman M; Barrett JA; Donevan S; Hedberg TG; Taylor CP
    J Pain; 2010 Dec; 11(12):1241-9. PubMed ID: 20472509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.
    Field MJ; Cox PJ; Stott E; Melrose H; Offord J; Su TZ; Bramwell S; Corradini L; England S; Winks J; Kinloch RA; Hendrich J; Dolphin AC; Webb T; Williams D
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17537-42. PubMed ID: 17088553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of recombinant N-type and native high voltage-gated neuronal Ca2+ channels by AdGABA: mechanism of action studies.
    Martínez-Hernández E; Sandoval A; González-Ramírez R; Zoidis G; Felix R
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):270-7. PubMed ID: 21059371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.
    Li Z; Taylor CP; Weber M; Piechan J; Prior F; Bian F; Cui M; Hoffman D; Donevan S
    Eur J Pharmacol; 2011 Sep; 667(1-3):80-90. PubMed ID: 21651903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin in partial epilepsy.
    Beydoun A; Nasreddine W; Atweh S
    Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
    Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
    Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats.
    McClelland D; Evans RM; Barkworth L; Martin DJ; Scott RH
    BMC Pharmacol; 2004 Aug; 4():14. PubMed ID: 15294026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for pain management.
    Gajraj NM
    Pain Pract; 2005 Jun; 5(2):95-102. PubMed ID: 17177755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
    Arnold L; Mease P; Silverman S
    Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo.
    Bauer CS; Rahman W; Tran-van-Minh A; Lujan R; Dickenson AH; Dolphin AC
    Biochem Soc Trans; 2010 Apr; 38(2):525-8. PubMed ID: 20298215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants.
    Lotarski SM; Donevan S; El-Kattan A; Osgood S; Poe J; Taylor CP; Offord J
    J Pharmacol Exp Ther; 2011 Aug; 338(2):615-21. PubMed ID: 21558437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.